As they shift from pediatric to adult care, young adult patients with sickle cell disease appear to visit the ER more often, ...

A clinical trial testing the oral therapy tebapivat for sickle cell disease is fully enrolled, with early results expected later this year.

Differences in red blood cell stiffness may help to explain variations in the severity of sickle cell disease (SCD), ...

The FDA has awarded breakthrough device designation to Hemex Health’s rapid diagnostic test for sickle cell disease and beta ...

Wilson explains how new experiences help him gather evidence that things can go well, even with sickle cell disease.

Pain is part of sickle cell disease crises, but columnist Oluwatosin Adesoye says it shouldn't keep you from pursuing goals.

The National Institutes of Health (NIH) has awarded a $6.1 million grant to the Feinstein Institutes for Medical Research to advance knowledge of red cell disorders, such as sickle cell disease (SCD), ...

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...

Emmaus Life Sciences has entered into an agreement to sell the North American rights to Endari (oral L-glutamine), its oral treatment to prevent acute complications related to sickle cell disease (SCD ...

FTX-6058 is an experimental small molecule treatment for sickle cell disease (SCD) being developed by Fulcrum Therapeutics. It aims to treat patients by raising levels of fetal hemoglobin in cells.

Although approximately 1 in 6 people worldwide are living with a significant disability, the narrative that those of us with disabilities deserve less continues to be perpetuated. Though frustrating, ...

A $1.9-million federal grant has been awarded to a clinical trial that seeks to find effective ways to improve adherence to hydroxyurea treatment among children and young adults with sickle cell ...